Suppr超能文献

探讨头颈部癌患者螺旋断层放疗中自适应放疗的必要性。

Investigating the necessity of adaptive radiotherapy in tomotherapy of head and neck cancer patients.

作者信息

Chaparian Ali, Kianinia Mahsa, Roayaei Mahnaz, Najafizade Nadia, Kanani Abolfazl, Mahani Leili, Nourzadeh Hamidreza

机构信息

Medical Image and Signal Processing Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Medical Physics Department, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Radiat Oncol. 2025 Jul 21;20(1):115. doi: 10.1186/s13014-025-02689-6.

Abstract

BACKGROUND

Anatomical variations that occur during radiation therapy in head and neck cancer (HNC) patients can lead to significant dosimetric changes. The purpose of this study is to evaluate dosimetric and volume changes in key anatomical structures for different treatment sites in HNC patients, and to determine the percentage of patients who need adaptive radiotherapy (ART) per treatment site.

METHODS

A total of 1,740 megavoltage computed tomography (MVCT) images from 58 HNC patients treated with helical tomotherapy (HT) were exported to the PreciseART™ (Accuray) software. Volume changes in the planning target volume (PTV) and the organs at risk (OARs) in the planning stage and the first and last fractions of treatment were calculated. The differences between the values of actual accumulated and initial plan doses were used to determine which patients benefit ART.

RESULTS

The average volume changes between the planning stage and the first fraction were 3.93%, 4.49%, and 6.46% for the PTV, brainstem, and spinal cord, respectively, for all patients. However, the average volume changes between the first and last fractions of treatment were relatively small and included 0.84%, 3.62%, and 1.19% for the PTV, brainstem, and spinal cord, respectively. The average dose changes between the initial planned dose and the actual cumulative dose in the last fraction were in the range of 10.43-30.81%; 4.66-11.61%; 3.73-9.97%; and - 0.17-5.40% for the brainstem, left parotid, right parotid, and spinal cord, respectively, for all patients. A maximum of 10.53%, 28.57%, and 18.18% of patients with oral cavity, larynx, and nasopharyngeal cancers, respectively, needed ART. Patients with salivary gland cancers did not need ART.

CONCLUSION

Although monitoring the volume and dose changes of the tumor and OARs during the course of radiation therapy is important, not all patients need ART. Criteria such as weight loss and rapid tumor shrinkage should be considered when selecting candidate patients for ART. The time interval between CT simulation and the first fraction also plays an important role in the difference in the volume and dose to organs during the course of radiation therapy.

摘要

背景

头颈部癌(HNC)患者在放射治疗期间出现的解剖变异可导致显著的剂量学变化。本研究的目的是评估HNC患者不同治疗部位关键解剖结构的剂量学和体积变化,并确定每个治疗部位需要适应性放射治疗(ART)的患者百分比。

方法

将58例接受螺旋断层放射治疗(HT)的HNC患者的1740张兆伏计算机断层扫描(MVCT)图像导出到PreciseART™(Accuray)软件中。计算计划靶体积(PTV)和危及器官(OARs)在计划阶段、治疗的第一分次和最后分次时的体积变化。实际累积剂量与初始计划剂量值之间的差异用于确定哪些患者能从ART中获益。

结果

所有患者的PTV、脑干和脊髓在计划阶段与第一分次之间的平均体积变化分别为3.93%、4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验